Agarwal, Arnav;
Agoritsas, Thomas;
Aertgeerts, Bert;
Coyac, Frederic;
Farhoumand, Pauline Darbellay;
Demaine, Andrew;
Fog Heen, Anja;
Foroutan, Farid;
Guyatt, Gordon H;
Jha, Vivekanand;
Li, Sheyu;
Machuve, Edward,;
Nagler, Evi;
Ponte, Belen;
Rayner, Daniel;
Tunnicliffe, David J;
Vandvik, Per Olav;
Zeng, Xiaoxi.
What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidneyoutcomes for adults living with chronic kidney disease (CKD)? Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors ha...
Levin, Adeera;
Ahmed, Sofia B;
Carrero, Juan Jesus;
Foster, Bethany;
Francis, Anna;
Hall, Rasheeda K;
Herrington, Will G;
Hill, Guy;
Inker, Lesley A;
Kazancıoğlu, Rümeyza;
Lamb, Edmund;
Lin, Peter;
Madero, Magdalena;
McIntyre, Natasha;
Morrow, Kelly;
Roberts, Glenda;
Sabanayagam, Dharshana;
Schaeffner, Elke;
Shlipak, Michael;
Shroff, Rukshana;
Tangri, Navdeep;
Thanachayanont, Teerawat;
Ulasi, Ifeoma;
Wong, Germaine;
Yang, Chih-Wei;
Zhang, Luxia;
Robinson, Karen A;
Wilson, Lisa;
Wilson, Renee F;
Kasiske, Bertram L;
Cheung, Michael;
Earley, Amy;
Stevens, Paul E.
Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...
Renal Insufficiency, Chronic/drug therapy,
Renal Insufficiency, Chronic/diagnosis,
Glomerular Filtration Rate,
Creatinine/analysis,
Serum Albumin/analysis,
Glycemic Control,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Sodium-Glucose Transporter 2 Inhibitors/therapeutic use,
Anemia/therapy
La enfermedad renal crónica (ERC) consiste en la pérdida progresiva de la función renal a
través de cinco estadios (1, 2). Esta condición es un problema de salud pública que ocasiona daños en la calidad de vida y pérdidas socioeconómicas por la mortalidad, discapacidad y costos asociados que gen...
Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones respecto al
diagnóstico, tratamiento y derivación de las personas con ERC....
Renal Insufficiency, Chronic/prevention & control,
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/drug therapy,
Glomerular Filtration Rate,
Proteinuria/urine,
Albuminuria/urine,
Antiviral Agents/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Hypolipidemic Agents/therapeutic use,
Insulin/therapeutic use
